Yin Jingjing, Qu Jianguo, Zhang Wenjie, Lu Dongrui, Gao Yucong, Ying Xixiang, Kang Tingguo
School of Pharmacy, Liaoning University of Traditional Chinese Medicine, Dalian, 116600, China.
Biomed Chromatogr. 2014 May;28(5):637-47. doi: 10.1002/bmc.3082. Epub 2013 Nov 20.
Hawthorn leaves, a well-known traditional Chinese medicine, have been widely used for treating cardiovascular and fatty liver diseases. The present study aimed to investigate the therapeutic basis treating fatty liver disease by comparing the tissue distribution of six compounds of hawthorn leaf extract (HLE) in fatty liver rats and healthy rats after oral administration at first day, half month and one month, separately. Therefore, a sensitive and specific HPLC method with internal standard was developed and validated to determine chlorogenic acid, vitexin-4''-O-glucoside, vitexin-2''-O-rhamnoside, vitexin, rutin and hyperoside in the tissues including heart, liver, spleen, kidney, stomach and intestine. The results indicated that the six compounds in HLE presented some bioactivity in treating rat fatty liver as the concentrations of the six compounds varied significantly in inter- and intragroup comparisons (healthy and/or fatty liver group).
山楂叶是一种著名的中药,已被广泛用于治疗心血管疾病和脂肪肝疾病。本研究旨在通过比较口服山楂叶提取物(HLE)六种化合物在脂肪肝大鼠和健康大鼠第一天、半月和一个月后的组织分布,来研究治疗脂肪肝疾病的基础。因此,建立并验证了一种灵敏、特异的内标HPLC方法,用于测定心脏、肝脏、脾脏、肾脏、胃和肠道组织中的绿原酸、牡荆素-4''-O-葡萄糖苷、牡荆素-2''-O-鼠李糖苷、牡荆素、芦丁和金丝桃苷。结果表明,HLE中的六种化合物在治疗大鼠脂肪肝方面具有一定的生物活性,因为这六种化合物的浓度在组间和组内比较(健康和/或脂肪肝组)中存在显著差异。